Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01120353 · ClinicalTrials.gov registry record
Childhood Cancer Survivor Study
A clinical trial of Cancer, sponsored by St. Jude Children's Research Hospital.
- Recruiting
- Registry status
- 50,000
- Enrollment target
- 20
- Study locations
NCT01120353: Recruiting study of Cancer, sponsored by St. Jude Children's Research Hospital.
NCT01120353 is a study of Cancer that is actively recruiting participants, run by St. Jude Children's Research Hospital. The registered enrollment target is 50,000 participants, above the 3,410-participant average among 615 other Cancer trials with a reported enrollment target (1366% higher). The trial reports 20 study locations across 12 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01120353, a study of Cancer, is actively recruiting participants, sponsored by St. Jude Children's Research Hospital.
- RECRUITING
- Registry status
- 50,000 participants
- Enrollment target
- 20
- Study locations
Study Summary
The Childhood Cancer Survivor Study (CCSS) will investigate the long-term effects of cancer and its associated therapies. A retrospective cohort study will be conducted through a multi-institutional collaboration, which will involve the identification and active follow-up of a cohort of approximately 50,000 survivors of cancer, diagnosed before 21 years of age, between 1970 and 1999 and 10,000 sibling controls. This project will study children and young adults exposed to specific therapeutic modalities, including radiation, chemotherapy, and/or surgery, who are at increased risk of late-occurring adverse health outcomes. A group of sibling controls will be identified and data collected for comparison purposes.
Conditions Studied
Study Locations (20)
California
- City of Hope National Medical Center - Duarte
- Children's Hospital Los Angeles - Los Angeles
- University of California-Los Angeles - Los Angeles
- Children's Hospital of Orange County - Orange
- University of California-San Francisco - San Francisco
- Stanford University School of Medicine - Stanford
Minnesota
- Children's Hospitals & Clinics of Minnesota - Minneapolis
- University of Minnesota - Minneapolis
- Mayo Clinic - Rochester
Illinois
- Ana & Robert H. Lurie Children's Hospital of Chicago - Chicago
- University of Chicago - Chicago
Alabama
- University of Alabama at Birmingham/Children's of Alabama - Birmingham
Colorado
- Children's Hospital Colorado - Aurora
District of Columbia
- Children's National Medical Center - Washington D.C.
Georgia
- Emory University/Children's Health Care of Atlanta - Atlanta
Indiana
- Indiana University/Riley Hospital for Children - Indianapolis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50,000 participants |
| Start Date | 1995-01-05 |
| Est. Completion | 2026-11 |
What NCT01120353 shows while recruiting
NCT01120353 is an observational study that tracks outcomes without assigning an intervention. Its 50,000 participants enrollment target places it among the larger protocols in the corpus, above the 3,410-participant average among 615 other Cancer trials with a reported enrollment target (1366% higher).
The record links to 1 condition, with Cancer appearing as the primary indexed condition, and to 0 interventions.
NCT01120353 names 20 study sites across 12 states, led by California, Minnesota, Illinois.
Frequently Asked Questions
What is clinical trial NCT01120353 about?
NCT01120353 is a clinical study titled "Childhood Cancer Survivor Study". The Childhood Cancer Survivor Study (CCSS) will investigate the long-term effects of cancer and its associated therapies. A retrospective cohort study will be conducted through a multi-institutional collaboration, which will involve the identification and active follow-up of a cohort of approximatel...
What is the current status of trial NCT01120353?
This trial is currently recruiting. The enrollment target is 50,000 participants. The study started on 1995-01-05. Estimated completion is 2026-11.
What conditions does trial NCT01120353 study?
This clinical trial studies the following conditions: Cancer.
Who is sponsoring clinical trial NCT01120353?
This trial is sponsored by St. Jude Children's Research Hospital, which has 410 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01120353 being conducted?
This trial has 20 study locations across Alabama, California, Colorado, District of Columbia, Georgia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01120353's enrollment target sits among peer trials
50,000 8th of 615 higher than 606 of 615 other Cancer trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Registry Study to Evaluate the Clinical Outcome of Cancer Patients and Benign Diseases Treated with Radiation
RECRUITING
-
Treatment of Immune Checkpoint Inhibitor-related Diarrhea and/ or Colitis With Ustekinumab in Cancer Patients
RECRUITING · Phase 2
-
IMPACT (IMproving Proactive Approaches for Cancer Survivors' Mental Health Treatment)
RECRUITING · NA
-
A Natural History Study of Metabolic Sizing in Health and Disease
RECRUITING
-
Development of Radiation Free Whole Body Magnetic Resonance (MR) Imaging Technique for Staging Children With Cancer
RECRUITING · Phase 1
-
Long-Term Follow-Up of Recipient of Gene Transfer Research
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00500123 · 50,000 participants
The Alpha-1 Foundation's and University of Florida's Alpha-1 Coded Testing (ACT) Study
- NCT01885299 · 50,000 participants
RSSearch Patient Registry-Long Term Study of Use of SRS/SBRT
- NCT04629586 · 50,000 participants
The T1D Exchange Registry
- NCT05497518 · 50,000 participants
The KidneyCARE (Community Access to Research Equity) Study
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI